ImmunityBio converts from Immunomedics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics

IBRX 2.110

-1.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: End2War who wrote (1032)	5/14/2025 9:45:01 PM
From: Olecranon	Read Replies (1) of 1229

I’m now using AI’s on an almost daily basis for one thing or another. But the press release provides zero transparency into the nuts and bolts of this “partnership”. Leaving room only for speculation. Supergrok concludes by saying the partnership offers significant opportunities, but we (and probably the rest of the investment community at this point in time), don’t really have any insight into how significant or how likely those opportunities are. The detailed analysis talks about: • potentially opening doors, • could facilitate • could accelerate • could drive additional revenue • may enable • suggests potential In short, I think this is one case where an A.I. is particularly guilty of glazing the user in its response. It’s nice to have a bullet point list of possible areas of benefit. But for every one of those areas we don’t really know if the likely benefit to IBRX is closer to $0 or $100M dollars. I do remain bullish on IBRX, despite the kneecapping that RFK Jr. has done to us. And I am glad the PSS is pursuing this. I hope it’s more than window dressing.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next